PRRT2 and diabetic kidney disease: Additionally, the critical role of hexacosanol (a component of BWA) has been illustrated as the modulation of nitric oxide synthetase and protein kinase C (PKC), leading to the prevention of glomerular sclerosis and improvement in diabetic nephropathy [56,57].